Background: Pseudomonas is a leading cause of nosocomial infections usually associated with high mortality. The aim of this study was to determine predictive factors of septic shock in patients with hematological malignancies and Pseudomonas infections.
Methods: This study was conducted in a teaching hospital (Aziza Othmana University hospital, Tunis, Tunisia) to evaluate the clinical profile of infection due to Pseudomonas species and to determine risk factors for septic shock defined according to the criteria of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Statistical analysis was performed with Pearson test.Level of significance was at p = 0.05.
Results: Between 2001 and 2009 a total of 80 Pseudomonas isolates (77 P.aeruginosa) was collected in 66 patients: 52 with acute leukemia (79%),7 with lymphoma (10.5%), and 7 with other hematological disorders (10.5%). The median age was 30 years (range, 2-64years). Most common sites of the isolates were from bloodstroom (45%), and skin lesions (31.5%). Median time for microbiological documentation was 8 days (range, 0-35days) from onset of neutropenia. At least 12 patients (18.1%) had recurrent (≥2) infections due to Pseudomonas. The most common clinical signs observed were: skin lesions (34%), diarrhea (20%), isolated fever (18%), and respiratory symptoms (14%). Susceptibility to major anti-Pseudomonas antibiotics revealed that isolates tested were resistant to: piperacillin/tazobactam (43%), ceftazidim (31%), imipenemcilastatin (26%), ciprofloxacin (25%), and amikacin (26%). Septic shock occured in 16.2% of episodes (13/80). Crude mortality was (19.6%,13 of the 66 patients) all caused by septic shock. For the remaining 53 patients (79.4%) median time for response to antibiotherapy was 2.5 days. In univariate analysis, factors associated with septic shock were: fever lasting for more than 3 days in patients on antibiotherapy (p = 0.019), Creactive protein > 150 mg/l (p = 0.065), serum lactate > 5mmol (p = 0.05), hemoglobin level < 50 g/l (p = 0.042), hypoproteinemia < 50 g/l (p = 0.01), and procalcitonin >10ng/ml (p = 0.031).
Conclusion:
This study revealed that several factors such as high procalcitonin level, low hemoglobin level, severe hypoproteinemia,high lactate level,and antibiotherapy >72 h before microbiological documentation are significant factors associated with septic shock and increased mortality in patients with hematological malignancies and Pseudomonas infections. doi:10.1016/j.ijid.2010.02.2047
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Initiatives to decrease the incidence and transmission of Clostridium difficile (C. difficile) J. Murillo 1 , V. Heitzer 2, * , M. Ruiz 3 , F. Ordieres 2 1 Miami, USA 2 South Miami hospital, 33143, Fl, USA 3 South Miami Hospital, Miami, Fl, USA Background: Due to the increased incidence and transmission of Clostridium difficile (C. diff) in healthcare facilities in our community, surveillance and a retrospective study for 2005 was conducted. We noted in our 2006 ongoing surveillance a gradual increase in the incidence of C. diff. in our facility.
Methods: We convened a multidisciplinary Task Force to address the increased incidence of C diff in 2006. The Task Force recommended the following actions: Contact isolation/precautions for all individuals with diarrhea, physician designed signage implemented to encourage hand antisepsis with soap and water followed by alcohol hand rinse for all patients with diarrhea, Fluoroquinolone evaluation was conducted and judicious prescribing practices for Fluoroquinolones was disseminated, yogurt twice a day was incorporated into patient's dietary regimen for those receiving antibiotic(s) or physicians whose patients disliked or were intolerant of yogurt were contacted by a dietitian to prescribe a prophylactic probiotic.
Results: Our data has demonstrated a sustained decrease in the incidence of C.diff. This was accomphished through hightened awareness of judicious prescribing of fluoroquinolones, institution of proper isolation/precautions of patients, by the addition of yogurt to patient dietary regimen or probiotic therapy, and staff acceptance and utilization of new hand hygiene products.
